this week target rm25....after QR RM35

Bonus to be announced soon gua!!!

https://www.orientaldaily.com.my/news/international/2020/07/24/353703

http://www.lustergroup.com/index.php

This is not kidding as this is experts said

Just like the anti-virus software need to be renewed yearly

sk9hian9

This is an "anti-virus" dose which need to be injected yearly or bi-yearly.....RM200 per dose i think is cheap and conservative price

Frankly, if the vaccine exist now, I think RM1k per dose, I'm willing to sponsor all my family to inject.

Harga kos vaksin mungkin dalam 2.5 euros (RM12) seunit. This is before mark up price. They sell to gov at cost, but after packaging and all the expenses, RM200 per dose is too cheap

haha.....so good to subsidize.....gov no money already, but anyhow Pharma & DPharma will benefited if gov subsidize

https://www.euronews.com/2020/07/20/uk-government-secures-90-million-c...

https://www.google.com/search?q=popultion+of+uk&oq=popultion+of+uk...-8

UK Population is around 66 millions, but their gov is buying 90 million doses of vaccine.

Malaysia case: around 30 million population, as I assume Malaysia buying 30 millions doses, let say RM200 per dose (which is conservative as I believe RM800, everyone also go n inject it).

Total Revenue: RM6 billions, divided 50-50 to Pharma & DPharma, means every yr, their revenue will have extra RM3B

https://www.euronews.com/2020/07/20/uk-government-secures-90-million-coronavirus-vaccine-doses

https://www.google.com/search?q=popultion+of+uk&oq=popultion+of+uk&aqs=chrome..69i57j0l7.5447j0j9&sourceid=chrome&ie=UTF-8https://www.google.com/search?q=popultion+of+uk&oq=popultion+of+uk&aqs=chrome..69i57j0l7.5447j0j9&sourceid=chrome&ie=UTF-8

UK Population is around 66 millions, but their gov is buying 90 million doses of vaccine.

Malaysia case: around 30 million population, as I assume Malaysia buying 30 millions doses, let say RM200 per dose (which is conservative as I believe RM800, everyone also go n inject it).

Total Revenue: RM6 billions, divided 50-50 to Pharma & DPharma, means every yr, their revenue will have extra RM3B

tomorrow another limit up

400k queuing at limit up price at RM4.55....wow

Other hospitals may get the vaccine, but all hospitals have to buy from Pharma & DPharma only

speakup: i want to buy covid vaccine. where to buy?

Answer by GOV: Pharma & DPharma only, sole distributors.

新冠肺炎｜曾祈殷：病毒不停變種　料市民或需每年接種疫苗。

英國牛津大學與中國工程院的新冠肺炎疫苗研發團隊昨日（21日）分別表示，疫苗試驗有積極進展，其中牛津大學疫苗已成功在所有接受試驗的人身上產生免疫反應。

牛津的實驗疫苗名為ChAdOx1 nCoV-19，目前已為1,077人注射進行測試。疫苗成功誘發人體免疫系統，產生抗體。不過目前未知抗體是否足夠對抗真正感染，實驗還需要一段時間證實效果。

感染及傳染病專科醫生曾祈殷今（22日）早接受商台節目《在晴朗的一天出發》訪問時表示，相信新冠肺炎會成為風土病，預料市民或需每年接種疫苗，像季節性流感。由於病毒不停變種，未來或需要不停研製新疫苗，更改其品種讓市民接種。

曾祈殷稱，大部份疫苗的原理是刺激人體免疫系統，從而達致免疫作用。全球20間參與研製新冠疫苗的藥廠，使用的抗原和方法都有所不同，他呼籲政府盡快諮詢專家委員會的意見，思考選購哪間藥廠的疫苗，動作不能太慢。他又稱，香港大學亦正研製新冠肺炎疫苗，完成後需再找本地或外國的藥廠合營。

曾祈殷續說，縱觀環球疫情沒完沒了，不論冬季、夏季也肆虐各地，相信新冠肺炎肯定會成為風土病，預料市民或需每年接種疫苗，像季節性流感。他又提到，由於病毒不停變種，可變強亦可變弱，未來或需要不停研製新疫苗，更改其品種讓市民接種.

This is something like a yearly renewable software = "renewable vaccine" as every year the vaccine need to be upgraded as the virus is getting stronger. Yearly or bi-yearly injection of vaccine is really a long term business, just like Microsoft office, or any license software (anti-virus) need to be renew yearly. Pharma & DPharma.

新冠肺炎｜曾祈殷：病毒不停變種　料市民或需每年接種疫苗。

英國牛津大學與中國工程院的新冠肺炎疫苗研發團隊昨日（21日）分別表示，疫苗試驗有積極進展，其中牛津大學疫苗已成功在所有接受試驗的人身上產生免疫反應。

牛津的實驗疫苗名為ChAdOx1 nCoV-19，目前已為1,077人注射進行測試。疫苗成功誘發人體免疫系統，產生抗體。不過目前未知抗體是否足夠對抗真正感染，實驗還需要一段時間證實效果。

感染及傳染病專科醫生曾祈殷今（22日）早接受商台節目《在晴朗的一天出發》訪問時表示，相信新冠肺炎會成為風土病，預料市民或需每年接種疫苗，像季節性流感。由於病毒不停變種，未來或需要不停研製新疫苗，更改其品種讓市民接種。

曾祈殷稱，大部份疫苗的原理是刺激人體免疫系統，從而達致免疫作用。全球20間參與研製新冠疫苗的藥廠，使用的抗原和方法都有所不同，他呼籲政府盡快諮詢專家委員會的意見，思考選購哪間藥廠的疫苗，動作不能太慢。他又稱，香港大學亦正研製新冠肺炎疫苗，完成後需再找本地或外國的藥廠合營。

曾祈殷續說，縱觀環球疫情沒完沒了，不論冬季、夏季也肆虐各地，相信新冠肺炎肯定會成為風土病，預料市民或需每年接種疫苗，像季節性流感。他又提到，由於病毒不停變種，可變強亦可變弱，未來或需要不停研製新疫苗，更改其品種讓市民接種.

This is something like a yearly renewable software = "renewable vaccine" as every year the vaccine need to be upgraded as the virus is getting stronger. Yearly or bi-yearly injection of vaccine is really a long term business, just like Microsoft office, or any license software (anti-virus) need to be renew yearly. Pharma & DPharma.

新冠肺炎｜曾祈殷：病毒不停變種　料市民或需每年接種疫苗。

英國牛津大學與中國工程院的新冠肺炎疫苗研發團隊昨日（21日）分別表示，疫苗試驗有積極進展，其中牛津大學疫苗已成功在所有接受試驗的人身上產生免疫反應。

牛津的實驗疫苗名為ChAdOx1 nCoV-19，目前已為1,077人注射進行測試。疫苗成功誘發人體免疫系統，產生抗體。不過目前未知抗體是否足夠對抗真正感染，實驗還需要一段時間證實效果。

感染及傳染病專科醫生曾祈殷今（22日）早接受商台節目《在晴朗的一天出發》訪問時表示，相信新冠肺炎會成為風土病，預料市民或需每年接種疫苗，像季節性流感。由於病毒不停變種，未來或需要不停研製新疫苗，更改其品種讓市民接種。

曾祈殷稱，大部份疫苗的原理是刺激人體免疫系統，從而達致免疫作用。全球20間參與研製新冠疫苗的藥廠，使用的抗原和方法都有所不同，他呼籲政府盡快諮詢專家委員會的意見，思考選購哪間藥廠的疫苗，動作不能太慢。他又稱，香港大學亦正研製新冠肺炎疫苗，完成後需再找本地或外國的藥廠合營。

曾祈殷續說，縱觀環球疫情沒完沒了，不論冬季、夏季也肆虐各地，相信新冠肺炎肯定會成為風土病，預料市民或需每年接種疫苗，像季節性流感。他又提到，由於病毒不停變種，可變強亦可變弱，未來或需要不停研製新疫苗，更改其品種讓市民接種.

This is something like a yearly renewable software = "renewable vaccine" as every year the vaccine need to be upgraded as the virus is getting stronger. Yearly or bi-yearly injection of vaccine is really a long term business, just like Microsoft office, or any license software (anti-virus) need to be renew yearly. Pharma & DPharma.

新冠肺炎｜曾祈殷：病毒不停變種　料市民或需每年接種疫苗。

英國牛津大學與中國工程院的新冠肺炎疫苗研發團隊昨日（21日）分別表示，疫苗試驗有積極進展，其中牛津大學疫苗已成功在所有接受試驗的人身上產生免疫反應。

牛津的實驗疫苗名為ChAdOx1 nCoV-19，目前已為1,077人注射進行測試。疫苗成功誘發人體免疫系統，產生抗體。不過目前未知抗體是否足夠對抗真正感染，實驗還需要一段時間證實效果。

感染及傳染病專科醫生曾祈殷今（22日）早接受商台節目《在晴朗的一天出發》訪問時表示，相信新冠肺炎會成為風土病，預料市民或需每年接種疫苗，像季節性流感。由於病毒不停變種，未來或需要不停研製新疫苗，更改其品種讓市民接種。

曾祈殷稱，大部份疫苗的原理是刺激人體免疫系統，從而達致免疫作用。全球20間參與研製新冠疫苗的藥廠，使用的抗原和方法都有所不同，他呼籲政府盡快諮詢專家委員會的意見，思考選購哪間藥廠的疫苗，動作不能太慢。他又稱，香港大學亦正研製新冠肺炎疫苗，完成後需再找本地或外國的藥廠合營。

曾祈殷續說，縱觀環球疫情沒完沒了，不論冬季、夏季也肆虐各地，相信新冠肺炎肯定會成為風土病，預料市民或需每年接種疫苗，像季節性流感。他又提到，由於病毒不停變種，可變強亦可變弱，未來或需要不停研製新疫苗，更改其品種讓市民接種.

This is something like a yearly renewable software = "renewable vaccine" as every year the vaccine need to be upgraded as the virus is getting stronger. Yearly or bi-yearly injection of vaccine is really a long term business, just like Microsoft office, or any license software (anti-virus) need to be renew yearly. Pharma & DPharma.

新冠肺炎｜曾祈殷：病毒不停變種　料市民或需每年接種疫苗。

英國牛津大學與中國工程院的新冠肺炎疫苗研發團隊昨日（21日）分別表示，疫苗試驗有積極進展，其中牛津大學疫苗已成功在所有接受試驗的人身上產生免疫反應。

牛津的實驗疫苗名為ChAdOx1 nCoV-19，目前已為1,077人注射進行測試。疫苗成功誘發人體免疫系統，產生抗體。不過目前未知抗體是否足夠對抗真正感染，實驗還需要一段時間證實效果。

感染及傳染病專科醫生曾祈殷今（22日）早接受商台節目《在晴朗的一天出發》訪問時表示，相信新冠肺炎會成為風土病，預料市民或需每年接種疫苗，像季節性流感。由於病毒不停變種，未來或需要不停研製新疫苗，更改其品種讓市民接種。

曾祈殷稱，大部份疫苗的原理是刺激人體免疫系統，從而達致免疫作用。全球20間參與研製新冠疫苗的藥廠，使用的抗原和方法都有所不同，他呼籲政府盡快諮詢專家委員會的意見，思考選購哪間藥廠的疫苗，動作不能太慢。他又稱，香港大學亦正研製新冠肺炎疫苗，完成後需再找本地或外國的藥廠合營。

曾祈殷續說，縱觀環球疫情沒完沒了，不論冬季、夏季也肆虐各地，相信新冠肺炎肯定會成為風土病，預料市民或需每年接種疫苗，像季節性流感。他又提到，由於病毒不停變種，可變強亦可變弱，未來或需要不停研製新疫苗，更改其品種讓市民接種.

This is something like a yearly renewable software = "renewable vaccine" as every year the vaccine need to be upgraded as the virus is getting stronger. Yearly or bi-yearly injection of vaccine is really a long term business, just like Microsoft office, or any license software (anti-virus) need to be renew yearly. Pharma & DPharma.

新冠肺炎｜曾祈殷：病毒不停變種　料市民或需每年接種疫苗。

英國牛津大學與中國工程院的新冠肺炎疫苗研發團隊昨日（21日）分別表示，疫苗試驗有積極進展，其中牛津大學疫苗已成功在所有接受試驗的人身上產生免疫反應。

牛津的實驗疫苗名為ChAdOx1 nCoV-19，目前已為1,077人注射進行測試。疫苗成功誘發人體免疫系統，產生抗體。不過目前未知抗體是否足夠對抗真正感染，實驗還需要一段時間證實效果。

感染及傳染病專科醫生曾祈殷今（22日）早接受商台節目《在晴朗的一天出發》訪問時表示，相信新冠肺炎會成為風土病，預料市民或需每年接種疫苗，像季節性流感。由於病毒不停變種，未來或需要不停研製新疫苗，更改其品種讓市民接種。

曾祈殷稱，大部份疫苗的原理是刺激人體免疫系統，從而達致免疫作用。全球20間參與研製新冠疫苗的藥廠，使用的抗原和方法都有所不同，他呼籲政府盡快諮詢專家委員會的意見，思考選購哪間藥廠的疫苗，動作不能太慢。他又稱，香港大學亦正研製新冠肺炎疫苗，完成後需再找本地或外國的藥廠合營。

曾祈殷續說，縱觀環球疫情沒完沒了，不論冬季、夏季也肆虐各地，相信新冠肺炎肯定會成為風土病，預料市民或需每年接種疫苗，像季節性流感。他又提到，由於病毒不停變種，可變強亦可變弱，未來或需要不停研製新疫苗，更改其品種讓市民接種.

This is something like a yearly renewable software = "renewable vaccine" as every year the vaccine need to be upgraded as the virus is getting stronger. Yearly or bi-yearly injection of vaccine is really a long term business, just like Microsoft office, or any license software (anti-virus) need to be renew yearly.

新冠肺炎｜曾祈殷：病毒不停變種　料市民或需每年接種疫苗。

英國牛津大學與中國工程院的新冠肺炎疫苗研發團隊昨日（21日）分別表示，疫苗試驗有積極進展，其中牛津大學疫苗已成功在所有接受試驗的人身上產生免疫反應。

牛津的實驗疫苗名為ChAdOx1 nCoV-19，目前已為1,077人注射進行測試。疫苗成功誘發人體免疫系統，產生抗體。不過目前未知抗體是否足夠對抗真正感染，實驗還需要一段時間證實效果。

感染及傳染病專科醫生曾祈殷今（22日）早接受商台節目《在晴朗的一天出發》訪問時表示，相信新冠肺炎會成為風土病，預料市民或需每年接種疫苗，像季節性流感。由於病毒不停變種，未來或需要不停研製新疫苗，更改其品種讓市民接種。

曾祈殷稱，大部份疫苗的原理是刺激人體免疫系統，從而達致免疫作用。全球20間參與研製新冠疫苗的藥廠，使用的抗原和方法都有所不同，他呼籲政府盡快諮詢專家委員會的意見，思考選購哪間藥廠的疫苗，動作不能太慢。他又稱，香港大學亦正研製新冠肺炎疫苗，完成後需再找本地或外國的藥廠合營。

曾祈殷續說，縱觀環球疫情沒完沒了，不論冬季、夏季也肆虐各地，相信新冠肺炎肯定會成為風土病，預料市民或需每年接種疫苗，像季節性流感。他又提到，由於病毒不停變種，可變強亦可變弱，未來或需要不停研製新疫苗，更改其品種讓市民接種.

This is something like a yearly renewable software = "renewable vaccine" as every year the vaccine need to be upgraded as the virus is getting stronger. Yearly or bi-yearly injection of vaccine is really a long term business, just like Microsoft office, or any license software (anti-virus) need to be renew yearly. This is really an explosive business!!!

Luster(5068) is a hidden GEM, as they produce many hygiene stuff for many branded players, like Initial (which 1 of the famous brand in Asia), and etc.

https://www.initial.com.my/hand-hygiene/

Luster(5068) is a hidden GEM, as they produce many hygiene stuff for many branded players, like Initial (which 1 of the famous brand in Asia), and etc.

https://www.initial.com.my/hand-hygiene/

Luster is a hidden GEM, as they produce many hygiene stuff for many branded players, like Initial (which 1 of the famous brand in Asia), and etc.

https://www.initial.com.my/hand-hygiene/

Speakup, you are here & DPharma, means gloves investors had diversified their funds into these counters......if 20-30% fund jumped into these counters, then it really can be like supermx up more than 1000%!!!

Speakup, you are here & Pharma, means gloves investors had diversified their funds into these counters......if 20-30% fund jumped into these counters, then it really can be like supermx up more than 1000%!!!

Supermx still good if you want to hold for next 5-10 yrs

tiantsai

I was supporter of Supermx, but situation has been changed, "if we don't change then we will be changed"!!! Hope others can realized this

https://www.theedgemarkets.com/article/oxfordastrazeneca-covid19-vaccine-study-shows-dual-immune-action

https://www.nst.com.my/world/world/2020/07/610175/two-coronavirus-vaccines-produce-immune-response-trials

Big 4 Glove are for THKS, Big 2 are for Pharma & DPharma or PD

V-Shape rebound were obviously supported by uncle, without him what do you think?

Pharma & DPharma easily can up 2-300% in next few months like glove from Mar-July

Switched all to Pharm & Dpharma!!! Bye bye glove!!!

Switched all to Pharm & Dpharma!!! Bye bye glove!!!

Switched all to Pharm & Dpharma!!! Bye bye glove!!!

Switched all to Pharm & Dpharma!!! Bye bye glove!!!

Switched all to Pharm & Dpharma!!! Bye bye glove!!!

Switched all to Pharm & Dpharma!!! Bye bye glove!!!

Switched all to Pharm & Dpharma!!! Bye bye glove!!!

cimb itrade hang...

Better give RM30 as the target, else every 2-3 days have to change again

https://www.9news.com.au/world/dam-blasted-to-release-surging-water-as-deadly-flooding-across-china-continues/1b8bf101-2b5d-4c70-bdc3-70b3de80ff4a

China glove production affected by flood seriously, ASP will shot up again. Now glove is not gold anymore, it is Diamond.

USA +73,388 cases yesterday, everyday record breaking towards 100k per day. Glove shall also break record daily

PAT RM1B, TP:RM30

Can park some profits of Scomnet & gloves into next GEM, Luster:

10 Apr 2020 Acquired
74,220,000 MR NG NGOON WENG
19 Mar 2020 Acquired
500,000 MR PHUAH CHENG PENG
19 Mar 2020 Acquired
500,000 MR PHUAH CHENG PENG
10 Oct 2019 Acquired
97,550,000 MR CHUAH CHONG EWE
10 Oct 2019 Acquired
97,550,000 MR CHUAH CHONG EWE

Bosses of Penta & Scomnet are there!!!

Can park some profits of Scomnet & gloves into next GEM, Luster:

10 Apr 2020 Acquired
74,220,000 MR NG NGOON WENG
19 Mar 2020 Acquired
500,000 MR PHUAH CHENG PENG
19 Mar 2020 Acquired
500,000 MR PHUAH CHENG PENG
10 Oct 2019 Acquired
97,550,000 MR CHUAH CHONG EWE
10 Oct 2019 Acquired
97,550,000 MR CHUAH CHONG EWE

Bosses of Penta & Scomnet are there!!!